Comments
The Competition Commission of India on Thursday approved Vivimed Laboratories’ sale of some products in its specialty chemicals division to drug firm Clariant Chemicals India. In September, Vivimed had signed a pact for sale of some products in its specialty chemicals division to Clariant Chemicals India for a consideration of about ₹380 crore. Analysts and traders will closely monitor further developments on this front.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.